Cancers Journal Introduction

Immune Suppression in Colorectal Cancer

Organoids Journal Introduction

Complex Organoid Models as Experimental Platform for Drug Discovery, Personalized Medicine, and Human Developmental Biology: Recent Advances and Future Challenges.

Prof. Dr. Subbaya Subramanian

Dr. Subbaya Subramanian is currently a Professor in the Department of Surgery at the University of Minnesota, United States. As a faculty at the University of Minnesota, Dr. Subramanian has established an internationally recognized cancer research program focused on deciphering the molecular mechanisms of antitumor immune evasion in cancer. His current research focuses on understanding the interactions between cancer and the host immune system and how cancer cells manipulate the antitumor immune response. Dr. Subramanian has authored over 120 peer-reviewed publications and has written numerous book chapters and review articles. He has delivered over 80 national and international invited lectures/seminars and received the American Cancer Society Research Scholar award.

Prof. Dr. Amélia Pilar Rauter

Prof. Dr. Amélia Pilar Rauter, a full professor, was the founder of the Portuguese Society of Chemistry Carbohydrate Chemistry Group in 1992, and the founder (2001) and leader of the CQB Carbohydrate Chemistry Group—FCUL, a center of excellence of the ESF network Euroglycoforum (2009–2014), and Executive of its Interest Group Glycochemistry. Presently, she is the leader of the CQE Carbohydrate Chemistry Group. She is the President of IUPAC Division of Organic and Biomolecular Chemistry (Division III), the Past-President of the International Carbohydrate Organisation, and the Secretary of the European Carbohydrate Organization.

Prof. Dr. Alfredo Berzal-Herranz

Prof. Dr. Fabrizio Schifano

Professor Fabrizio Schifano, Chair in clinical pharmacology and therapeutics; consultant psychiatrist, Psychopharmacology, Drugs of Misuse and Novel Psychoactive Substances Research Unit; School of Life and Medical Sciences, University of Hertfordshire (UK)

Dr. Eric O. Freed

Dr. Eric Freed received his Ph.D. in 1990 in the laboratories of Drs. Rex Risser and Howard Temin at the University of Wisconsin–Madison and performed postdoctoral work with Dr. Temin at UW–Madison and Malcolm Martin at the NIAID/NIH. Since 2015, he has served as Director of the HIV Dynamics and Replication Program in the Center for Cancer Research, National Cancer Institute, NIH. He is also the Co-Director of the University of Maryland Virology Program. He is an elected fellow of the American Society for Microbiology and in 2018 was awarded the KT Jeang Retrovirology Prize. In addition to serving as the founding editor-in-chief of Viruses, Dr. Freed is an editor for Science Advances, Journal of Molecular Biology, and Fields Virology.

Prof. Dr. Cord Brakebusch

Dr. Cord Brakebusch studied Biochemistry at the University of Hannover , Germany, and received his diploma 1989. After carrying out his PhD work on TNF receptors in the lab of David Wallach at the Weizmann Institute of Science in Rehovot, Israel, he received his PhD 1993 from the University of Hannover and started a post doc with Axel Ullrich at the Max Planck Institute of Biochemistry in Munich, Germany, on an extracellular matrix compound with anti-cancer properties. 1996 he joined the group of Reinhard Fässler, where he learned how to generate and analyze mice with targeted mutations and investigated the function of b1 integrin in vivo. Together with Reinhard Fässler he moved 1998 to the University of Lund, Sweden, where he obtained a fellowship as an assistant professor from the Swedish Medical Research Council. 2002 he received a Heisenberg Fellowship, which allowed him to establish an independent research group focusing on the function of Rho GTPases in vivo at the Max Planck Institute of Biochemistry in Munich at the Department of Molecular Medicine, headed by Reinhard Fässler. In 2006 Cord Brakebusch moved to Copenhagen to become professor at the University of Copenhagen, Faculty of Health, and director of the Transgenic Mouse Core Facility. Since 2007 he is in addition a group leader at BRIC.

Prof. Dr. Süleyman Ergün